DrugPatentWatch Database Preview
VELETRI Drug Profile
When do Veletri patents expire, and what generic alternatives are available?
Veletri is a drug marketed by Actelion Pharms Ltd and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in VELETRI is epoprostenol sodium. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the epoprostenol sodium profile page.
Summary for VELETRI
| International Patents: | 18 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 19 |
| Clinical Trials: | 1 |
| Patent Applications: | 541 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VELETRI |
| DailyMed Link: | VELETRI at DailyMed |
Pharmacology for VELETRI
| Drug Class | Prostacycline Vasodilator |
| Physiological Effect | Vasodilation |
Medical Subject Heading (MeSH) Categories for VELETRI
US Patents and Regulatory Information for VELETRI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-002 | Jun 28, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-001 | Jun 27, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-002 | Jun 28, 2012 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Actelion Pharms Ltd | VELETRI | epoprostenol sodium | INJECTABLE;INJECTION | 022260-001 | Jun 27, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for VELETRI
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 0. 5m/vial and1.5 mg/vial | ➤ Subscribe | ➤ Sign Up |
International Patents for VELETRI
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 5415771 | ➤ Sign Up |
| Slovenia | 1993557 | ➤ Sign Up |
| Denmark | 1993557 | ➤ Sign Up |
| Cyprus | 1117128 | ➤ Sign Up |
| Russian Federation | 2008135701 | ➤ Sign Up |
| Portugal | 1993557 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
